Evidence map›Paper›PMID 37212216›Full record

Trial reportIntegrative cancer therapies

Effects of Tuina Combined With Moxibustion on Breast Cancer-Related Lymphedema: A Randomized Cross-Over Controlled Trial.

Chunhui Wang, Heng Liu, Jing Shen, Yanfang Hao, Le Zhao, Yingyi Fan, Xiaohua Pei

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chunhui WangFangshan Hospital, Beijing University of Chinese Medicine, Beijing, China.ORCID 0000-0001-6686-1696
Heng LiuFangshan Hospital, Beijing University of Chinese Medicine, Beijing, China.
Jing ShenFangshan Hospital, Beijing University of Chinese Medicine, Beijing, China.
Yanfang HaoFangshan Hospital, Beijing University of Chinese Medicine, Beijing, China.
Le ZhaoThe Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.
Yingyi FanThe Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.
Xiaohua PeiXiamen Hospital, Beijing University of Chinese Medicine, Xiamen, Fujian Province, China.ORCID 0000-0003-3043-8874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study is to evaluate the effect of Tuina combined with moxibustion on relieving breast cancer-related lymphedema (BCRL). A randomized cross-over controlled trial was conducted at our institution. All patients with BCRL were assigned to 2 groups: Group A and Group B. In the first period (weeks 1-4), tuina and moxibustion were performed in Group A and pneumatic circulation and compression garment in Group B. The washout period took place from weeks 5 to 6. In the second period (weeks 7-10), pneumatic circulation and compression garment were performed in Group A, and tuina and moxibustion in Group B. Therapeutic efficacy was evaluated by measuring the affected arm volume, circumference, and Visual Analog Scale for swelling. Regarding the results, a total of 40 patients were included, and 5 cases were dropped. After treatment, both the traditional Chinses medicine (TCM) treatment and complete decongestive therapy (CDT) was found to reduce the volume of the affected arm (

Indexed as

Breast Cancer LymphedemaBreast NeoplasmsLymphedemaMoxibustionFemaleHumansTreatment OutcomeUpper Extremitybreast cancer-related lymphedemamoxibustionrandomized cross-over controlled trialtraditional Chinese medicinetuina

Identifiers

PMID37212216
PMCPMC10214059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.